NO20013442L - Sammensetninger som oppnar en forbedret levering av aktive stoffer - Google Patents
Sammensetninger som oppnar en forbedret levering av aktive stofferInfo
- Publication number
- NO20013442L NO20013442L NO20013442A NO20013442A NO20013442L NO 20013442 L NO20013442 L NO 20013442L NO 20013442 A NO20013442 A NO 20013442A NO 20013442 A NO20013442 A NO 20013442A NO 20013442 L NO20013442 L NO 20013442L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- active substances
- improved delivery
- delivery
- improved
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11537899P | 1999-01-11 | 1999-01-11 | |
PCT/US2000/000575 WO2000041693A2 (en) | 1999-01-11 | 2000-01-10 | Compositions having improved delivery of actives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013442D0 NO20013442D0 (no) | 2001-07-11 |
NO20013442L true NO20013442L (no) | 2001-09-11 |
Family
ID=22361013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013442A NO20013442L (no) | 1999-01-11 | 2001-07-11 | Sammensetninger som oppnar en forbedret levering av aktive stoffer |
Country Status (15)
Country | Link |
---|---|
US (1) | US6846495B2 (es) |
EP (1) | EP1140093A2 (es) |
JP (1) | JP2002534463A (es) |
KR (1) | KR100511730B1 (es) |
CN (1) | CN1203854C (es) |
AU (1) | AU762366B2 (es) |
BR (1) | BR0007445A (es) |
CA (1) | CA2356881C (es) |
CO (1) | CO5270007A1 (es) |
CZ (1) | CZ20012491A3 (es) |
HU (1) | HUP0105021A3 (es) |
NO (1) | NO20013442L (es) |
PE (1) | PE20001415A1 (es) |
TR (1) | TR200101927T2 (es) |
WO (1) | WO2000041693A2 (es) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5599961B2 (ja) * | 2000-03-09 | 2014-10-01 | ジーダブリュー・ファーマ・リミテッド | 薬学的組成物 |
EP1321140B1 (en) * | 2000-08-25 | 2005-04-06 | Kowa Company, Ltd. | Ibuprofen solutions for capsule-filling and capsule preparations |
US7138133B2 (en) | 2001-10-10 | 2006-11-21 | The Procter & Gamble Company | Orally administered liquid compositions |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
MX2007006233A (es) | 2004-11-24 | 2007-11-23 | Medpointe Healthcare Inc | Composiciones que comprenden azelastina y metodos de uso de la misma. |
EA013616B1 (ru) * | 2005-02-01 | 2010-06-30 | Троикаа Фармасьютикалз Лтд. | Инъекционные препараты диклофенака и его фармацевтически приемлемых солей |
BRPI0710292A2 (pt) | 2006-04-05 | 2011-08-09 | Cadbury Adams Usa Llc | complexo de fosfato de cálcio em uma goma de mascar contendo ácido |
WO2007117627A2 (en) | 2006-04-05 | 2007-10-18 | Cadbury Adams Usa Llc | Calcium phosphate complex and salts in oral delivery systems |
BRPI0713879A2 (pt) * | 2006-06-29 | 2012-11-06 | Cadbury Adams Usa Llc | cortador de corrente aperfeiçoado para a formação de pedaços recheados com goma no centro |
US20090029018A1 (en) * | 2007-07-27 | 2009-01-29 | Cadbury Adams Usa Llc | Method and apparatus for processing confectionery products |
DE102007000521A1 (de) * | 2007-10-18 | 2009-04-23 | Renate Conrad | Hustenpräparat |
PL2380965T3 (pl) † | 2008-02-08 | 2014-08-29 | Procter & Gamble | Sposób wytwarzania rozpuszczalnej w wodzie saszetki |
US9303038B2 (en) | 2011-09-06 | 2016-04-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological diseases |
AU2013257706A1 (en) | 2012-05-07 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for the treatment of neurological disorders |
AU2013257742A1 (en) | 2012-05-07 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
US9309233B2 (en) | 2012-05-08 | 2016-04-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of blood clotting disorders |
WO2013168023A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of parkinson's disease |
WO2013167991A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic disorders |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
WO2013168033A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neurologic diseases |
US9315478B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
WO2013168014A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of familial amyloid polyneuropathy |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
SG11201407318UA (en) | 2012-05-10 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of metabolic syndrome |
WO2013168015A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of asthma and allergy |
US9273061B2 (en) | 2012-05-10 | 2016-03-01 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
WO2013168004A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of fibromyalgia pain |
US9315461B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
WO2013168000A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of severe pain |
EP2852569B1 (en) | 2012-05-23 | 2020-10-14 | Cellixbio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
WO2013175376A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of local pain |
SG11201407326XA (en) | 2012-05-23 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for treatment of mucositis |
WO2013175344A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
NZ701832A (en) | 2012-05-23 | 2016-08-26 | Cellix Bio Private Ltd | Compositions and methods for treatment of inflammatory bowel disease |
US9227974B2 (en) | 2012-05-23 | 2016-01-05 | Cellex Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
WO2014020480A2 (en) | 2012-08-03 | 2014-02-06 | Mahesh Kandula | Compositions and methods for the treatment migraine and neurologic diseases |
US9624168B2 (en) | 2012-09-06 | 2017-04-18 | Cellix Bio Private Limited | Compositions and methods for the treatment inflammation and lipid disorders |
GB201215988D0 (en) * | 2012-09-07 | 2012-10-24 | Reckitt Benckiser Healthcare Int Ltd | Pharmaceutical compositions comprising flurbiprofen |
CA2873029A1 (en) | 2012-09-08 | 2014-03-13 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammation and lipid disorders |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
SG11201509782TA (en) | 2013-06-04 | 2015-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of diabetes and pre-diabetes |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
EP3240779B1 (en) | 2014-09-26 | 2020-10-28 | Cellixbio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
WO2016051420A1 (en) | 2014-09-29 | 2016-04-07 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
EP3212626B1 (en) | 2014-10-27 | 2018-11-07 | Cellix Bio Private Limited | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
CA2969188C (en) * | 2014-12-12 | 2023-05-02 | Ari Healthcare Pvt. Ltd. | A mouth freshener |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
SG11201705524SA (en) | 2015-01-06 | 2017-08-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of inflammation and pain |
US11234897B2 (en) * | 2017-03-27 | 2022-02-01 | DXM Pharmaceutical, Inc. | Packaged multi-dose liquid dextromethorphan hydrobromide formulation |
MX2020012233A (es) | 2018-05-16 | 2021-01-29 | Bayer Healthcare Llc | Formula de suspension de alta concentracion para medicamentos en capsula de gel blanda para resfriado y gripe. |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE611639A (es) * | 1960-12-28 | |||
US4136163A (en) | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
CA1027347A (en) | 1972-07-20 | 1978-03-07 | David G. Rowsell | Compounds having a physiological cooling effect and compositions containing them |
SE7812207L (sv) | 1977-12-01 | 1979-06-02 | Welsh Nat School Med | Apparat, forfarande och framstellda produkter for anvendning vid administration av antihistaminer |
US4474985A (en) | 1981-07-06 | 1984-10-02 | Monsanto Company | Purification of N-acetyl aminophenols |
JPS5888334A (ja) | 1981-11-20 | 1983-05-26 | Takasago Corp | 3−l−メントキシプロパン−1、2−ジオ−ル |
US4478822A (en) | 1983-05-16 | 1984-10-23 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
US4474752A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Drug delivery system utilizing thermosetting gels |
GB8629567D0 (en) | 1986-12-10 | 1987-01-21 | Boots Co Plc | Therapeutic agents |
IE59934B1 (en) | 1987-06-19 | 1994-05-04 | Elan Corp Plc | Liquid suspension for oral administration |
US4883660A (en) * | 1988-10-17 | 1989-11-28 | Thames Pharmacal Co., Inc. | Gel bases for pharmaceutical compositions |
US5196486A (en) | 1989-03-17 | 1993-03-23 | Nalco Chemical Company | Alkoxylated vinyl polymer demulsifiers |
US5100898A (en) | 1990-01-25 | 1992-03-31 | Richardson-Vicks Inc. | Antitussive liquid compositions containing dyclonine |
SK42593A3 (en) * | 1990-10-31 | 1993-09-09 | Procter & Gamble | Antitusic agents |
US5196436A (en) | 1990-10-31 | 1993-03-23 | The Procter & Gamble Company | Dextromethorphan antitussive compositions |
US5141961A (en) | 1991-06-27 | 1992-08-25 | Richrdson-Vicks Inc. | Process for solubilizing difficulty soluble pharmaceutical actives |
WO1994018970A1 (en) | 1993-02-18 | 1994-09-01 | Warner-Lambert Company | Cold/sinus preparation consisting of phenindamine tartarate with or without therapeutic agents |
US5505961A (en) | 1993-08-05 | 1996-04-09 | R. P. Scherer Corporation | Gelatin capsules containing a highly concentrated acetaminophen solution |
CA2181241C (en) | 1994-01-24 | 2000-04-25 | Dadi Jamshed Dhabhar | Process for solubilizing difficultly soluble pharmaceutical actives |
US5510389A (en) | 1994-03-02 | 1996-04-23 | The Procter & Gamble Company | Concentrated acetaminophen solution compositions |
US5458879A (en) | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
US5616621A (en) | 1995-01-30 | 1997-04-01 | American Home Products Corporation | Taste masking liquids |
US5846557A (en) * | 1996-03-20 | 1998-12-08 | Cumberland Packing Corporation | Chewing gum containing cough suppressing agent |
US5955098A (en) | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
ES2234010T3 (es) | 1996-04-12 | 2005-06-16 | Novadel Pharma Inc. | Aerosol bucal polar. |
SE9601528D0 (sv) * | 1996-04-23 | 1996-04-23 | Pharmacia Ab | Transdermally administered dextromethorphan as antitissue agent |
US6027746A (en) * | 1997-04-23 | 2000-02-22 | Warner-Lambert Company | Chewable soft gelatin-encapsulated pharmaceutical adsorbates |
AU7916798A (en) | 1997-05-22 | 1998-12-11 | Boots Company Plc, The | Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat |
EP1952802A3 (en) | 1997-10-01 | 2009-06-17 | Novadel Pharma Inc. | Buccal, polar and non-polar spray or capsule |
-
1999
- 1999-12-20 US US09/466,950 patent/US6846495B2/en not_active Expired - Fee Related
-
2000
- 2000-01-10 HU HU0105021A patent/HUP0105021A3/hu unknown
- 2000-01-10 AU AU29627/00A patent/AU762366B2/en not_active Ceased
- 2000-01-10 CZ CZ20012491A patent/CZ20012491A3/cs unknown
- 2000-01-10 BR BR0007445-4A patent/BR0007445A/pt not_active Application Discontinuation
- 2000-01-10 EP EP00908243A patent/EP1140093A2/en not_active Withdrawn
- 2000-01-10 KR KR10-2001-7008796A patent/KR100511730B1/ko not_active IP Right Cessation
- 2000-01-10 JP JP2000593304A patent/JP2002534463A/ja active Pending
- 2000-01-10 CN CNB008026920A patent/CN1203854C/zh not_active Expired - Fee Related
- 2000-01-10 CA CA2356881A patent/CA2356881C/en not_active Expired - Fee Related
- 2000-01-10 WO PCT/US2000/000575 patent/WO2000041693A2/en not_active Application Discontinuation
- 2000-01-10 PE PE2000000017A patent/PE20001415A1/es not_active Application Discontinuation
- 2000-01-10 TR TR2001/01927T patent/TR200101927T2/xx unknown
- 2000-01-11 CO CO00001049A patent/CO5270007A1/es not_active Application Discontinuation
-
2001
- 2001-07-11 NO NO20013442A patent/NO20013442L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20013442D0 (no) | 2001-07-11 |
CA2356881A1 (en) | 2000-07-20 |
EP1140093A2 (en) | 2001-10-10 |
HUP0105021A3 (en) | 2003-02-28 |
TR200101927T2 (tr) | 2001-11-21 |
CO5270007A1 (es) | 2003-04-30 |
HUP0105021A2 (hu) | 2002-05-29 |
BR0007445A (pt) | 2001-10-16 |
CN1203854C (zh) | 2005-06-01 |
WO2000041693A3 (en) | 2000-11-30 |
WO2000041693A2 (en) | 2000-07-20 |
CA2356881C (en) | 2012-02-28 |
CZ20012491A3 (cs) | 2001-12-12 |
PE20001415A1 (es) | 2001-01-05 |
AU762366B2 (en) | 2003-06-26 |
CN1336823A (zh) | 2002-02-20 |
KR100511730B1 (ko) | 2005-08-31 |
KR20010093255A (ko) | 2001-10-27 |
JP2002534463A (ja) | 2002-10-15 |
US20030139437A1 (en) | 2003-07-24 |
US6846495B2 (en) | 2005-01-25 |
AU2962700A (en) | 2000-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013442L (no) | Sammensetninger som oppnar en forbedret levering av aktive stoffer | |
NO20004627L (no) | Aerosolifisert levering av aktive virkemidler | |
NO20042807L (no) | Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser | |
FR2804025B1 (fr) | Compositions pharmaceutiques stabilisees | |
NO20026037L (no) | Sötvareprodukt som inneholder aktive bestanddeler | |
NO20035654D0 (no) | System for avlevering av törrpulverformuleringer | |
NO20013742D0 (no) | Spiselige beleggblandinger | |
PT1242087E (pt) | Composicoes farmaceuticas | |
EE04450B1 (et) | Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele | |
IL163552A (en) | Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same | |
DZ3170A1 (fr) | Livraison de produits pharmaceutiques instables. | |
EE04799B1 (et) | Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
ZA200109236B (en) | Pharmaceutical compositions of erythropoietin. | |
WO2002051424A8 (fr) | Medicaments contre les defaillances articulaires | |
ATE312511T1 (de) | Synergistische insektizide zusammensetzungen | |
NO20042739L (no) | Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan | |
WO2000066104A3 (en) | Ace-2 inhibiting compounds and methods of use thereof | |
HUP0400832A3 (en) | New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients | |
DK1458377T3 (da) | Farmaceutiske sammensætninger indeholdende tegaserod | |
BR0013860B1 (pt) | composições aerossóis eletrostáticas. | |
PT1173434E (pt) | Novo produto farmaceutico | |
NO20040860L (no) | Farmasoytisk sammensetning som innbefatter lumiracoxib | |
FR2802423B1 (fr) | Compositions pharmaceutiques | |
DK1083790T3 (da) | Retardformuleringer af aktive stoffer til plantebeskyttelse | |
PT102384A (pt) | Composicoes farmaceuticas compreendendo metanossulfonato de paroxentina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |